Skip to main content
ConductScienceScienceDex

Chang, Aileen

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #4,655
Unclaimed recordClaim profile
  • Program Leader
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2020 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2023 award categories

  • Internal Medicine

NIH Funding · FY2023

Linked Award Amount
$1.8M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#4,655
By linked amount among FY2023 PIs
Earliest Year Loaded
2020
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Chang, Aileen. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Chang, Aileen as a PI. Multi-PI records show the full award amount for context.

  • 5U01AR079717-02U01Contact PI
    Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection
    George Washington University · Internal Medicine (NIH department code)
    $1.5M
    award amount
  • 3U01AR079717-02S1U01Contact PI
    Cutting Edge Pain Research in the Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH) Trial
    George Washington University · Internal Medicine (NIH department code)
    $259.7K
    award amount

Award organization

Organizations that administered FY2023 awards listing Chang, Aileen as a PI.

FY2023 award administered by George Washington University (DC).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2020
    First NIH Award
    George Washington University
  2. 2020
    $500K Cumulative Funding
  3. 2020
    Entered Top 50% Nationally
    Ranked #9980
  4. 2022
    $1M Cumulative Funding
  5. 2022
    $2M Cumulative Funding
  6. 2022
    Entered Top 25% Nationally
    Ranked #4461
  7. 2022
    Program/Center Grant Leader

Explore further

Find collaborators for Chang, Aileen

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →